NCT05607043

Brief Summary

A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral RNA using an FDA approved RT-PCR test for SARS-CoV2- an RNA RT-PCR assay (Accurate Diagnostics)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 31, 2021

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 31, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 7, 2022

Completed
10 months until next milestone

Results Posted

Study results publicly available

September 13, 2023

Completed
Last Updated

September 22, 2023

Status Verified

September 1, 2023

Enrollment Period

25 days

First QC Date

October 31, 2022

Results QC Date

July 13, 2023

Last Update Submit

September 13, 2023

Conditions

Keywords

ScreeningLab-based testingAsymptomatic patientsPerception of safetyFeasibility

Outcome Measures

Primary Outcomes (6)

  • Patient Willingness to Participate in the Study

    Percentage of 36 patients who were approached to enroll in the study who actually enrolled

    Day 1

  • Willingness/Ability to Follow Through With the Study With Surveys, Triage and Testing

    Percentage of patients who complete the study

    26 days

  • Patient Test Completion

    Percentage of patients with completed SARS-CoV-2 testing

    Day 1

  • Percentage of Subjects Who Complete Study Activities to Optimize Gap Between Testing and Study Visit

    Percentage of subjects completing study activities within the defined optimal window

    From initial consent through study completion- approximately 4 weeks

  • Ease of Complying With Protocol

    Number of participants indicating that it was easy to complete the surveys

    Day 26

  • Percent of Patients Who Completed All of the Required Surveys

    Percentage of patients participating in the study who completed pre-visit, triage and post-visit surveys

    1 week

Study Arms (1)

SARS-CoV-2 testing

OTHER

There is only one arm in this study- the study is a non-randomized pilot. All the subjects will be tested for SARS CoV 2 viral infection as described.

Device: Testing for SARS CoV2 RNA

Interventions

Device: Testing for SARS CoV2 RNA- lab-based RNA RT-PCR testing

SARS-CoV-2 testing

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult 18 years or older; reporting to the Rutgers School of Dental Medicine for a dental visit

You may not qualify if:

  • Previous participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers School of Dental Medicine

Newark, New Jersey, 07103, United States

Location

Related Publications (3)

  • American Dental Association COVID-19 Toolkit - Update to Office Procedures During COVID-19. https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/resources/coronavirus/update_to_office_procedures_during_covid19.pdf accessed on November 11, 2021.

    BACKGROUND
  • Estrich CG, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, Araujo MWB. Estimating COVID-19 prevalence and infection control practices among US dentists. J Am Dent Assoc. 2020 Nov;151(11):815-824. doi: 10.1016/j.adaj.2020.09.005.

    PMID: 33071007BACKGROUND
  • Shirazi S, Stanford CM, Cooper LF. Testing for COVID-19 in dental offices: Mechanism of action, application, and interpretation of laboratory and point-of-care screening tests. J Am Dent Assoc. 2021 Jul;152(7):514-525.e8. doi: 10.1016/j.adaj.2021.04.019. Epub 2021 May 4.

    PMID: 34176567BACKGROUND

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Results Point of Contact

Title
Gayathri Subramanian, PhD, DMD
Organization
Rutgers School of Dental Medicine, Newark, New Jersey, United States

Study Officials

  • Cecile A Feldman

    Rutgers School of Dental Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Pilot study to assess feasibility of testing asymptomatic dental patients for SARS-CoV-2 antigen using lab-based RNA RT-PCR testing
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 31, 2022

First Posted

November 7, 2022

Study Start

January 31, 2021

Primary Completion

February 25, 2021

Study Completion

February 25, 2021

Last Updated

September 22, 2023

Results First Posted

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

If the COVID test results show that a participant is positive for COVID-19, the study staff will tell the participant the results. The study staff will be required to give the participant's name to the state's Department of Public Health if the participant tests positive because this is the law. At the end of the study, de-identified data will be provided to the National Coordinating Center.

Locations